AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2022
Jan 18, 2022
33483_dirs_2022-01-18_8bcf571b-98c9-46c2-978e-9b9c884d10fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2022-01-14
Reporting Person: BARABE TIMOTHY C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-14 | Common Stock | M | 10000 | $2.10 | Acquired | 200013 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-14 | Stock Option (Right to Buy) | $2.1 | M | 10000 | Disposed | 2029-06-13 | Common Stock (10000.0) | Direct |
Footnotes
F1: This option is fully vested.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8